hyperlipidemia and mixed dyslipidemia
Showing 1 - 1 of 1
Hyperlipidemia and Mixed Dyslipidemia Trial in Worldwide (Evolocumab, Standard of Care)
Completed
- Hyperlipidemia and Mixed Dyslipidemia
- Evolocumab
- Standard of Care
-
Birmingham, Alabama
- +362 more
May 20, 2019